These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1357919)

  • 41. The retinoblastoma gene is involved in malignant progression of astrocytomas.
    Henson JW; Schnitker BL; Correa KM; von Deimling A; Fassbender F; Xu HJ; Benedict WF; Yandell DW; Louis DN
    Ann Neurol; 1994 Nov; 36(5):714-21. PubMed ID: 7979217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Utility of EGFR and PTEN numerical aberrations in the evaluation of diffusely infiltrating astrocytomas. Laboratory investigation.
    Mott RT; Turner KC; Bigner DD; McLendon RE
    J Neurosurg; 2008 Feb; 108(2):330-5. PubMed ID: 18240930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic value of loss of heterozygosity around three candidate tumor suppressor genes on chromosome 10q in astrocytomas.
    Terada K; Tamiya T; Daido S; Kambara H; Tanaka H; Ono Y; Matsumoto K; Ito S; Ouchida M; Ohmoto T; Shimizu K
    J Neurooncol; 2002 Jun; 58(2):107-14. PubMed ID: 12164681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular analysis of the TSC1 and TSC2 tumour suppressor genes in sporadic glial and glioneuronal tumours.
    Parry L; Maynard JH; Patel A; Hodges AK; von Deimling A; Sampson JR; Cheadle JP
    Hum Genet; 2000 Oct; 107(4):350-6. PubMed ID: 11129334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. WHO grade-specific comparative genomic hybridization pattern of astrocytoma - a meta-analysis.
    Holland H; Koschny T; Ahnert P; Meixensberger J; Koschny R
    Pathol Res Pract; 2010 Oct; 206(10):663-8. PubMed ID: 20570053
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The putative tumor suppressor gene FHIT at 3p14.2 is rarely affected by loss of heterozygosity in primary human brain tumors.
    Frank S; Müller J; Plaschke J; Hahn M; Hampl J; Hampl M; Pistorius S; Schackert G; Schackert HK
    Cancer Res; 1997 Jul; 57(13):2638-41. PubMed ID: 9205070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple sequential molecular abnormalities in the evolution of human gliomas.
    Venter DJ; Thomas DG
    Br J Cancer; 1991 May; 63(5):753-7. PubMed ID: 1674878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Somatic mutations of the von Hippel-Lindau tumor suppressor gene and loss of heterozygosity on chromosome 3p in human glial tumors.
    Kanno H; Shuin T; Kondo K; Yamamoto I; Ito S; Shinonaga M; Yoshida M; Yao M
    Cancer Res; 1997 Mar; 57(6):1035-8. PubMed ID: 9067265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of heterozygosity for 10q loci in human gliomas.
    Rasheed BK; Fuller GN; Friedman AH; Bigner DD; Bigner SH
    Genes Chromosomes Cancer; 1992 Jul; 5(1):75-82. PubMed ID: 1384665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.
    Nakamura M; Ishida E; Shimada K; Kishi M; Nakase H; Sakaki T; Konishi N
    Lab Invest; 2005 Feb; 85(2):165-75. PubMed ID: 15592495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absence of mutation of the p73 gene in astrocytic neoplasms.
    Alonso ME; Bello MJ; Lomas J; Gonzalez-Gomez P; Arjona D; De Campos JM; Gutierrez M; Isla A; Vaquero J; Rey JA
    Int J Oncol; 2001 Sep; 19(3):609-12. PubMed ID: 11494043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.
    Cropp CS; Lidereau R; Campbell G; Champene MH; Callahan R
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7737-41. PubMed ID: 1977164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Karyotype analyses of 20 human glioma cell lines.
    Westphal M; Hänsel M; Hamel W; Kunzmann R; Hölzel F
    Acta Neurochir (Wien); 1994; 126(1):17-26. PubMed ID: 8154317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas.
    Rosso SM; van Dekken H; Krishnadath KK; Alers JC; Kros JM
    J Neuropathol Exp Neurol; 1997 Oct; 56(10):1125-31. PubMed ID: 9329456
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence of allelic imbalance of chromosome 6 in human astrocytomas.
    Liang BC; Ross DA; Greenberg HS; Meltzer PS; Trent JM
    Neurology; 1994 Mar; 44(3 Pt 1):533-6. PubMed ID: 7908424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical and pathologic analysis of astrocytic tumors with loss of heterozygosity on chromosome 10q].
    Zhou FA; Li JZ; Ma YQ; Miao N; Liu X; Li XX; Zhang W
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):618-21. PubMed ID: 23157831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A rapid and non-radioactive PCR based assay for the detection of allelic loss in human gliomas.
    von Deimling A; Bender B; Louis DN; Wiestler OD
    Neuropathol Appl Neurobiol; 1993 Dec; 19(6):524-9. PubMed ID: 7510049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequency of p53 tumor suppressor gene mutations in human primary brain tumors.
    Wu JK; Ye Z; Darras BT
    Neurosurgery; 1993 Nov; 33(5):824-30; discussion 830-1. PubMed ID: 7903434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma.
    Zainuddin N; Jaafart H; Isa MN; Abdullah JM
    Neurol Res; 2004 Jan; 26(1):88-92. PubMed ID: 14977064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival.
    Tada K; Shiraishi S; Kamiryo T; Nakamura H; Hirano H; Kuratsu J; Kochi M; Saya H; Ushio Y
    J Neurosurg; 2001 Oct; 95(4):651-9. PubMed ID: 11596960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.